» Articles » PMID: 20833712

Polycystin-2 Activity is Controlled by Transcriptional Coactivator with PDZ Binding Motif and PALS1-associated Tight Junction Protein

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Sep 14
PMID 20833712
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent monogenic cause of kidney failure, characterized by the development of renal cysts. ADPKD is caused by mutations of the polycystin-1 (PC1) or polycystin-2 (PC2) genes. PC2 encodes a Ca(2+)-permeable cation channel, and its dysfunction has been implicated in cyst development. The transcriptional coactivator with PDZ binding motif (TAZ) is required for the integrity of renal cilia. Its absence results in the development of renal cysts in a knock-out mouse model. TAZ directly interacts with PC2, and it has been suggested that another yet unidentified PDZ domain protein may be involved in the TAZ/PC2 interaction. Here we describe a novel interaction of TAZ with the multi-PDZ-containing PALS1-associated tight junction protein (PATJ). TAZ interacts with both the N-terminal PDZ domains 1-3 and the C-terminal PDZ domains 8-10 of PATJ, suggesting two distinct TAZ binding domains. We also show that the C terminus of PC2 strongly interacts with PDZ domains 8-10 and to a weaker extent with PDZ domains 1-3 of PATJ. Finally, we demonstrate that both TAZ and PATJ impair PC2 channel activity when co-expressed with PC2 in oocytes of Xenopus laevis. These results implicate TAZ and PATJ as novel regulatory elements of the PC2 channel and might thus be involved in ADPKD pathology.

Citing Articles

DLG1 functions upstream of SDCCAG3 and IFT20 to control ciliary targeting of polycystin-2.

Rezi C, Aslanyan M, Diwan G, Cheng T, Chamlali M, Junger K EMBO Rep. 2024; 25(7):3040-3063.

PMID: 38849673 PMC: 11239879. DOI: 10.1038/s44319-024-00170-1.


DLG1 functions upstream of SDCCAG3 and IFT20 to control ciliary targeting of polycystin-2.

Rezi C, Aslanyan M, Diwan G, Cheng T, Chamlali M, Junger K bioRxiv. 2023; .

PMID: 37987012 PMC: 10659422. DOI: 10.1101/2023.11.10.566524.


PATJ inhibits histone deacetylase 7 to control tight junction formation and cell polarity.

Fiedler J, Moennig T, Hinrichs J, Weber A, Wagner T, Hemmer T Cell Mol Life Sci. 2023; 80(11):333.

PMID: 37878054 PMC: 10600057. DOI: 10.1007/s00018-023-04994-3.


Yap controls notochord formation and neural tube patterning by integrating mechanotransduction with and expression.

Cheng C, Cong Q, Liu Y, Hu Y, Liang G, Dioneda K Sci Adv. 2023; 9(24):eadf6927.

PMID: 37315133 PMC: 10266736. DOI: 10.1126/sciadv.adf6927.


Research Progress on PATJ and Underlying Mechanisms Associated with Functional Outcomes After Stroke.

Wang W, Lyu T, Li Z Neuropsychiatr Dis Treat. 2021; 17:2811-2818.

PMID: 34471355 PMC: 8405222. DOI: 10.2147/NDT.S310764.


References
1.
Shin K, Straight S, Margolis B . PATJ regulates tight junction formation and polarity in mammalian epithelial cells. J Cell Biol. 2005; 168(5):705-11. PMC: 2171825. DOI: 10.1083/jcb.200408064. View

2.
Nauli S, Alenghat F, Luo Y, Williams E, Vassilev P, Li X . Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003; 33(2):129-37. DOI: 10.1038/ng1076. View

3.
Streets A, Wagner B, Harris P, Ward C, Ong A . Homophilic and heterophilic polycystin 1 interactions regulate E-cadherin recruitment and junction assembly in MDCK cells. J Cell Sci. 2009; 122(Pt 9):1410-7. PMC: 2671929. DOI: 10.1242/jcs.045021. View

4.
Nauli S, Kawanabe Y, Kaminski J, Pearce W, Ingber D, Zhou J . Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation. 2008; 117(9):1161-71. PMC: 3071982. DOI: 10.1161/CIRCULATIONAHA.107.710111. View

5.
Hossain Z, Mohamed Ali S, Ko H, Xu J, Peng Ng C, Guo K . Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc Natl Acad Sci U S A. 2007; 104(5):1631-6. PMC: 1785239. DOI: 10.1073/pnas.0605266104. View